Navigation Links
AngioDynamics pledges $500,000 to Society of Interventional Radiology Foundation
Date:4/2/2013

online at www.SIRweb.org. For more information about the Discovery Campaign or to learn more about the Society of Interventional Radiology Foundation, visit online at www.SIRFoundation.org.

About the Society of Interventional Radiology Foundation

SIR Foundation is a scientific foundation dedicated to fostering research and education in interventional radiology for the purposes of advancing scientific knowledge, increasing the number of skilled investigators in interventional radiology and developing innovative therapies that lead to improved patient care and quality of life. Visit SIR Foundation.org.

About the Society of Interventional Radiology

Interventional radiologists are physicians who specialize in minimally invasive, targeted treatments. They offer the most in-depth knowledge of the least invasive treatments available coupled with diagnostic and clinical experience across all specialties. They use X-ray, MRI and other imaging to advance a catheter in the body, such as in an artery, to treat at the source of the disease internally. As the inventors of angioplasty and the catheter-delivered stent, which were first used in the legs to treat peripheral arterial disease, interventional radiologists pioneered minimally invasive modern medicine. Today, interventional oncology is a growing specialty area of interventional radiology. Interventional radiologists can deliver treatments for cancer directly to the tumor without significant side effects or damage to nearby normal tissue.

Many conditions that once required surgery can be treated less invasively by interventional radiologists. Interventional radiology treatments offer less risk, less pain and less recovery time compared to open surgery. Visit www.SIRweb.org.

About AngioDynamics

AngioDynamics Inc. i
'/>"/>

SOURCE Society of Interventional Radiology Foundation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of AngioDynamics Inc. in Connection with Executive Compensation
2. Spine Pain Management, Inc. Completes $500,000 Private Placement
3. Sanofi Donates $500,000 to Hurricane Sandy for Immediate and Long-Term Relief Efforts
4. Salix Pharmaceuticals Donates $500,000 To ASGEs IT&T Capital Campaign To Build A New State-of-the-Art GI Training Center
5. Genalyte Awarded $500,000 SBIR Grant To Develop Multiplexed Assays For Early Detection And Monitoring Of Type 1 Diabetes
6. Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences
7. Stereotaxis Epoch™ Solutions Momentum Drives Strong Presence at the Heart Rhythm Society (HRS) Annual Meeting
8. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
9. NVA237 Phase III GLOW2 Data at American Thoracic Society (ATS) International Conference and Phase II Clinical Trial Update
10. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
11. Mylan Sponsors Drug Store News and Pharmacist Society to Provide a New Business Networking Platform for Pharmacy Schools and Students
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Calif. , Aug. 1, 2014  Isis Pharmaceuticals, ... initiation of a pivotal Phase 3 study evaluating ISIS-SMN ... the most common genetic cause of infant mortality. Isis ... within the next few weeks, at which time Isis ... development partner, Biogen Idec. The Phase 3 study, ENDEAR, ...
(Date:8/1/2014)... Aug. 1, 2014 Inovio Pharmaceuticals, Inc. (NYSE ... conference call to report its second quarter 2014 financial ... ET. CEO Dr. J. Joseph Kim and ... earnings, provide a corporate update, and participate in a ... development plans for VGX-3100, Inovio,s immune therapy targeting pre-cancers ...
(Date:8/1/2014)... Aug. 1, 2014 Arena Pharmaceuticals, Inc. ... corporate update and reported financial results for the ... "We have continued to see encouraging advancements ... 43% quarter-over-quarter increase in estimated total prescriptions and ... mark," said Jack Lief, Arena,s President and Chief ...
Breaking Medicine Technology:Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 2Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 3Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 4Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 5Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 2Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 2Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 4Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 5Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 6Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 7Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 8Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 9Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 10Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 11
(Date:8/1/2014)... use among young people has spiked, with 29.3 percent ... at least once and 17 percent admitting to regular use ... ‘Yes to Life,’ volunteers from the Church of Scientology of ... information about drugs, to help reverse this alarming trend. , ... Say ‘Yes’ to Life,” volunteers have distributed 40,000 copies of ...
(Date:8/1/2014)... appetite and whole-body metabolism. A protein known as PPARγ ... and body weight, but the identity of the neurons ... new study in the Journal of Clinical Investigation ... neuron known as pro-opiomelanocortin (POMC) neurons is critical in ... and colleagues at Yale University School of Medicine found ...
(Date:8/1/2014)... FRIDAY, Aug. 1, 2014 (HealthDay News) -- The U.S. ... approved a new drug, Jardiance, to help fight type ... alone or added to existing treatment regimens to control ... Dr. Curtis Rosebraugh, director of the Office of Drug ... and Research, said in an agency statement. The ...
(Date:8/1/2014)... Summer is here, and with it comes the season of ... can be a pain for dogs. Animal Emergency & Referral ... get rid of ticks and prevent them completely. , Female ... which is why they are so active during this season. ... and carry a number of diseases, including lyme disease, babesiosis ...
(Date:8/1/2014)... of a cancer diagnosis may improve health outcomes for ... by a researcher at the University of Houston (UH). ... intervention is the writing instruction. Otherwise, writing is just ... journal can be therapeutic, but oftentimes we don,t get ... not," said Qian Lu, assistant professor and director of ...
Breaking Medicine News(10 mins):Health News:Addressing a Serious Issue Affecting German Teens 2Health News:FDA Approves New Type 2 Diabetes Drug 2Health News:Tis the Season for Tick Prevention 2Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3
... Core Administration Software with ... PLANO, Texas, May 15 Perot Systems (NYSE:,PER) ... Core,Administration Software. Xcelys 5.0 software is a continuance of ... health plan market., Xcelys, formerly called PERADIGM software, ...
... of shingles cases, expert says , , THURSDAY, May ... older should be vaccinated against shingles, a condition that ... Disease Control and Prevention recommended on Thursday. , This ... 2006, after the ZOSTAVAX vaccine was approved by the ...
... pump inhibitors (PPIs) to control gastroesophageal reflux disease ... take them continue to experience breakthrough, which is ... regurgitation and heartburn. These breakthrough symptoms lead more ... (OTC) remedies, according to a survey recently conducted ...
... YORK, May 15 Pharmaceutical research and,development (R&D) is ... years and,a billion dollars of investment to turn a ... journey from discovery to market, is filled,with challenges. For ... makes it to the market. "From Molecule to Medicine," ...
... that,the U.S. Court of Appeals for the Federal Circuit ... District Court for the Central District of,California in the ... As a result of the Court of Appeals, ruling, ... Sanofi-aventis is considering all its legal options., While ...
... Diabetes,Wholesale (ADW), a discount provider of diabetic supplies, is ... network. ADW hopes to,expand its online reach and strengthen ... affiliate partners a percentage of every sale they refer.,Commissions ... our affiliate,program as a great way to cultivate an ...
Cached Medicine News:Health News:Perot Systems Announces the Launch of Xcelys(TM) 5.0 Software 2Health News:CDC Recommends Shingles Vaccine for Those Over 60 2Health News:CDC Recommends Shingles Vaccine for Those Over 60 3Health News:Nearly 40 percent of GERD patients taking PPIs experience recurring symptoms 2Health News:Nearly 40 percent of GERD patients taking PPIs experience recurring symptoms 3Health News:District Court Decision Affirmed in U.S. Lovenox(R) (enoxaparin sodium) Patent Infringement Case 2Health News:American Diabetes Wholesale Launches Affiliate Program 2
Microalbumin Linearity Control...
Total IgE Control...
The K-ASSAY Lipid Controls are assayed controls produced from fresh human sera to monitor the accuracy and precision of quantitative lipid determinations of human sera specimens....
The K-ASSAY hs-CRP Control Set is intended to be used as a consistent test sample of known concentrations for monitoring the performance of hs-CRP (high sensitive C-Reactive Protein) immunoturbimetri...
Medicine Products: